Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Pharmacy Practice in Focus: Health Systems May 2025 Volume 14 Issue 3 APhA 2025: GLP-1 Receptor Agonists vs SGLT2 Inhibitors Show Varied Benefit for Cardiovascular Outcomes in Patients With Diabetes Alana Hippensteele, Lead Editor Key Takeaways GLP-1 receptor agonists excel in stroke prevention, weight loss, and glycemic control, with significant reductions in major adverse cardiovascular events
The imputation model was a linear regression of the endpoint with gender as factor and baseline value of the endpoint, timing and the value of last available observation on study (LAO-OS) of the endpoint as covariates, imputed by treatment status
Follow standard laboratory reconstitution and handling protocols
Moisturize : Use fragrance-free, dye-free moisturizers, applying them post-shower to lock in moisture
Always discuss your treatment goals with your clinician, especially if youre using a GLP-1 to manage menopause-related weight changes
US$ 28.37
US$ 26.25
US$ 24.65
US$ 23.28
US$ 20.46
US$ 24.60
US$ 28.16
US$ 29.84
